Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

322 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

NCT00075192

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Research Site La Masa, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Gallatin, Tennessee, United States
  • Research Site Hermitage, Tennessee, United States
View Trial Details
Completed

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

NCT00283062

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Macquarie Park, Australia
  • Sanofi-Aventis Administrative Office Vienna, Austria
  • Sanofi-Aventis Administrative Office São Paulo, Brazil
View all 17 locations
View Trial Details
Completed

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

NCT00031187

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • West Los Angeles - VA Healthcare Center Los Angeles, California, United States
  • VA Medical Center of Palo Alto Palo Alto, California, United States
View Trial Details
Completed

Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer

NCT00137436

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Pfizer Investigational Site Harvey, Illinois, United States
  • Pfizer Investigational Site Tinley Park, Illinois, United States
  • Pfizer Investigational Site Hobart, Indiana, United States
  • Pfizer Investigational Site Munster, Indiana, United States
View all 24 locations
View Trial Details
Completed

XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer

NCT00417079

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • sanofi-aventis US Bridgewater, New Jersey, United States
  • sanofi-aventis Argentina Buenos Aires, Argentina
  • sanofi-aventis Belgium Diegem, Belgium
  • sanofi-aventis Brazil São Paulo, Brazil
View all 26 locations
View Trial Details

Related conditions